Gossamer Bio Inc. (GOSS) Tops Q2 EPS by 4c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.45), $0.04 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Restaurant Brands International (QSR) PT Raised to $86 at Guggenheim